ARCHIVES

DCT Board Pediatric Phase 1 Studies, Effort to Assess Obstacles To Clinical Trials

This article is from The Cancer Letter archive.

Vol. 10 No. 27 | July 6, 1984

Download PDF Visit The Full Archive

Related Articles

Karen Antman recruited to NCI on an IPA to oversee changes to centers, SPORE programs.

October 31, 2003

No Interest Seen Yet In Specialized Centers For Environmental Carcinogenesis

September 26, 1975

Critics Told To Back Waste Charges Or Shut Up

November 23, 1974

DeVita On Problems Of Drug Response: There May be Tw Populations Of Cells; Molecular Medicine will Change Treatment

December 13, 1991

GAO Report To Include Some But Not all Of Obey’s Charges

June 24, 1977

In Brief: Judith Salerno Named President and CEO of Komen

June 21, 2013